In an interview with PharmaShots, Monica Mann, Head of Global Medical, Multiple Sclerosis at Biogen shares her views on the Plegridy and how it works on MS patients. She also shed light on the approval of the therapy in the US and EU.
Shots:
The approval of Plegridy (IM) by the EC and the US FDA is based on…
